chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse effects reported; patient was vaccinated with improperly stored MMR II; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 05-JUN-2019, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (albumin status rHA) one dose, lot # R024906 with expiration date 30-AUG-2020 (frequency, route and anatomical location were not provided) which was reconstituted with sterile diluent (dose, frequency, route, lot number and expiration date were not provided) for prophylaxis. No adverse effects reported.  The temperature and time frame were unknown by reporter. There was previously temperature excursions and digital data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011469: US-009507513-1907USA010301: US-009507513-1907USA010302: US-009507513-1907USA010303: US-009507513-1907USA010304: US-009507513-1907USA010305: US-009507513-1907USA010306: US-009507513-1907USA010307: US-009507513-1907USA010308: US-009507513-1907USA010309: US-009507513-1907USA010310: US-009507513-1907USA010311: US-009507513-1907USA010312: US-009507513-1907USA010313: US-009507513-1907USA010314: US-009507513-1907USA010315: US-009507513-1907USA010316: US-009507513-1907USA010317: US-009507513-1907USA010318: US-009507513-1907USA010319: US-009507513-1907USA010320: US-009507513-1907USA010321: US-009507513-1907USA010322: US-009507513-1907USA010323: US-009507513-1907USA010324: US-009507513-1907USA010325: US-009507513-1907USA010326: US-009507513-1907USA010327: US-009507513-1907USA010328: US-009507513-1907USA010329: US-009507513-1907USA010330: US-009507513-1907USA010331: US-009507513-1907USA010332: US-009507513-1907USA010333: US-009507513-1907USA010334: US-009507513-1907USA010335: US-009507513-1907USA010336: US-009507513-1907USA010337: US-009507513-1907USA010338: US-009507513-1907USA010339: US-009507513-1907USA010340: US-009507513-1907USA010341: US-009507513-1907USA010342: US-009507513-1907USA010343: US-009507513-1907USA010344: US-009507513-1907USA010345: US-009507513-1907USA010346: US-009507513-1907USA010347: US-009507513-1907USA010348: US-009507513-1907USA010349: US-009507513-1907USA010350: US-009507513-1907USA010351: US-009507513-1907USA010352: US-009507513-1907USA010353: US-009507513-1907USA010354: US-009507513-1907USA010355: US-009507513-1907USA010356: US-009507513-1907USA010357: US-009507513-1907USA010358: US-009507513-1907USA010359: US-009507513-1907USA010360: US-009507513-1907USA010361: US-009507513-1907USA010362: US-009507513-1907USA010363: US-009507513-1907USA010364: US-009507513-1907USA010365: US-009507513-1907USA010366: US-009507513-1907USA010367: US-009507513-1907USA010368: US-009507513-1907USA010369: US-009507513-1907USA010370: US-009507513-1907USA010372: US-009507513-1907USA010373:
She got her vaccine, she then noticed that her hair was thinning out, which is the whole center of her head, the back and at the sites at the temple.  She went to the doctor and she checked her thyroid and that was not the problem.  She said that all of her blood work does not indicate anything that would indicate hair loss.  She was not given anything for it.  She has an APT with a dermatologist on 12/7/22.  The hair is thinned out really bad, and when she washes her hair you can see the entire scalp and the back of her head.   She told her what she found on the internet, and that she only listens to clinical reports.     She has always have fine thin hair, but never baldness showing  This did not happen with the other vaccines, only got really really tired with the third vaccine and could not stay away, and had 2 friends who had the response.  After the 4th vaccine she noticed the hair loss.
administered a dose of expired Infanrix; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 16-month-old female patient who received DTPa (Infanrix) (batch number 9BC23, expiry date 30th January 2022) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 31st January 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 31st January 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated they inadvertently administered a dose of expired Infanrix, which led to expired vaccine used. The reporter called in to inquire and report that the dose was valid and they should revaccinate. The reporter did not consent to follow-up.
Localized red raised rash (multiple) near injection site. No systemic reaction. Rash on the right thigh.
1 day after immunization, patient had an area of erythema and induration on L upper arm measuring 4x4". Also complained of pain and itchiness.
Rapid heart rate within 2 minutes of injection, the feeling of pins and needles in my face. Waited at site for 30 minutes, sucked on candy and drank water. Laid down in my car. Left after 30 min. Sat up, and it happened again. Every ten minutes my face would be tingly.  Bad taste in mouth.   Was told by onsite physician, I had a vasovagal response. 2 hours post injection and I feel better.
Event started with pain at the vaccination site on the left arm on around 07/28/2021. Pain subsided after a few days.  Sporadic tingling sensations from the vaccination site to the end of the finger tips followed (07/30/2021-08/02/2021). After that, the arm is numb. It has been numb for almost a week now.  There are brief moments when it has full sensitivity.
Chills; fever of 100 degrees.; Sore joints; woke up with a 103 degree fever; He also has a little bit of a runny nose; Cough; Felt tired again; Chills; Felt a little tired; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (He also has a little bit of a runny nose), COUGH (Cough), FATIGUE (Felt a little tired), FATIGUE (Felt tired again) and the first episode of CHILLS (Chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (Felt a little tired). On 28-Feb-2021, the patient experienced RHINORRHOEA (He also has a little bit of a runny nose), COUGH (Cough), FATIGUE (Felt tired again), the first episode of CHILLS (Chills), PYREXIA (woke up with a 103 degree fever) and ARTHRALGIA (Sore joints). On 01-Mar-2021, the patient experienced the second episode of CHILLS (Chills) and PYREXIA (fever of 100 degrees.). At the time of the report, RHINORRHOEA (He also has a little bit of a runny nose), COUGH (Cough), FATIGUE (Felt a little tired), FATIGUE (Felt tired again), the last episode of CHILLS (Chills), PYREXIA (woke up with a 103 degree fever), PYREXIA (fever of 100 degrees.) and ARTHRALGIA (Sore joints) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
he didn't have any antibodies; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (he didn't have any antibodies) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. unknown and unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced ANTIBODY TEST NEGATIVE (he didn't have any antibodies). At the time of the report, ANTIBODY TEST NEGATIVE (he didn't have any antibodies) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Antibody test: negative Blood test for antibodies after Covid-19 vaccination negative.         On 1Apr2021, he had a blood test. The antibodies were tested at the time. Blood test showed that he didn't have any antibodies.  Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
hand shaking; low grade temperature; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (hand shaking) and PYREXIA (low grade temperature) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] and VITAMIN B NOS for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TREMOR (hand shaking) and PYREXIA (low grade temperature). At the time of the report, TREMOR (hand shaking) and PYREXIA (low grade temperature) outcome was unknown.            Treatment information was not provided by the reporter.
I started developing a metallic taste in my mouth, congestion, fatigue, sore throat.
After vaccination, pt arm was swollen up & purple. After 3wks of injection, patients arm is still sore & stiff.
On 02/04/2023, I began to feel headache, sinus congestion, sore throat, chest congestion and cough. I went to the urgent care and had a COVID-19 test and a Strep test. COVID-19 was positive. Strep test was negative. The doctor gave me a PAXLOVID prescription, which I did take.
Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021; No adverse event; patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021), PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient got 1 dose of Moderna Covid-19 vaccine last yr on 12Nov2021 with expiry date on 08-Nov-2021) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator was 12-Nov-2021, product expiry date 08-Nov-2021).    Concomitant drugs were not reported. It was reported that the monovalent vial of size 5.5 ml was initially stored in refrigerator on 12-Nov-2021  The vial did not underwent any temperature excursion. Treatment medications were not provided.
I suffered a small stroke before the vaccine and started feeling sick with headache at 9pm which lasted about 6 days took doctor prescribed Nurtec, Ubrelvy and Sumatriptan 50mg. Headaches have subsided with OTC Benadryl.
About 8 hrs p/vax pt vomiting unable to keep formula down; mom called nurse & then put baby on pedialyte; no temp or local rxn; mom gave baby APAP;
Three days after the vaccine, onset of dizziness, headache and light headed with muscle aches.  Sinus pain.
35 y/o F w/ L arm pain & diffuse body ache.  s/p vaccination on 4/14/08.  Also c/o painful L axillary lymph node w/ fevers 103 degrees and chills.  c/o RUQ pain, nausea, vomiting.  Denies melena, diarrhea, constipation, dysuria.  IV abx given and pain control. 6/3/08-ER records received for DOS 4/15/08-DX: Vaccine reaction. Fever. Splenomegaly. Diabetes.
Severe, numerous ulcers on tonsils, throat, roof of mouth and inner lips.
HCP states she "has a patient who received their 1st dose of the PBCV on 21Sep2021 and then 90 days ago had Covid-19."; HCP states she "has a patient who received their 1st dose of the PBCV on 21Sep2021 and then 90 days ago had Covid-19."; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 21Sep2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02Dec2021, outcome "unknown" and all described as "HCP states she "has a patient who received their 1st dose of the PBCV on 21Sep2021 and then 90 days ago had Covid-19."".  Clinical information: HCP stated she "has a patient who received their 1st dose of the PBCV on 21Sep2021 and then 90 days ago had Covid-19." Does the patient now get the second dose or restart the PBCV series? HCP has no patient demographics available.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship, a possible causal association between the events and suspect drug BNT162B2 cannot be excluded.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Apr2021 as dose 1, single (Lot number: PAA165969), on 10May2021 as dose 2, single (Lot number: EW0185) and on 22Nov2021 as dose 3 (booster), single (Lot number: 32030930) at the age of 54 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course information: It was reported that the patient had no known allergies and the patient was not taking any other medications in 2 weeks.  No follow-up attempts are possible. No further information is expected.
Approximately 24 hours after dose, patient experienced lightheadedness, headache and lethargy, and was unable to stand or exert themselves without support. Patient suffered hot flashes, nausea.persisted for approximately 24 hours thereafter. No significant symptoms between time of vaccination and onset of symptoms 24h later.
Numbness, tingling immediately after vaccine within about 15 minutes. Then, on 10/16/2014 experienced near fainting and paralysis in arms, legs and face.
modern shot #2. Beginning 23 hours after dose, lasting 4 hours,   1.  sustained high fever 102-103 , even after Advils.  2.  Teeth chattering Shivering,  3.  Sustained tachycardia 4 hours when lying down 96+ 4. booming headache 5. sore arm, sore neck 6. achy body 7. pulsatile tinnutis ( I thought workers were hammering outside) 8. incredible thirst, drank (2) 27 oz thermoses of water at the 27 hour mark
full body hot flush; flushing; Hives; red with dots all over her stomach; Rash along her stomach; Rapid heart beat; Difficult to go to sleep; little rash on her stomach; felt weird; Residual weakness; Immediate sensation all over body; Tingling; Headache; This spontaneous case was reported by a physician and describes the occurrence of DYSAESTHESIA (Immediate sensation all over body), PARAESTHESIA (Tingling), FEELING ABNORMAL (felt weird), ASTHENIA (Residual weakness) and RASH ERYTHEMATOUS (Rash along her stomach) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 016M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (allergy to codeine). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Anxiety, ROSUVASTATIN CALCIUM (ROSUVASTIN) for Hypercholesterolemia, ESTRADIOL (ESTROGEN) for Menopause.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced DYSAESTHESIA (Immediate sensation all over body), PARAESTHESIA (Tingling), FEELING ABNORMAL (felt weird), ASTHENIA (Residual weakness), HEART RATE INCREASED (Rapid heart beat), INSOMNIA (Difficult to go to sleep), RASH (little rash on her stomach) and HEADACHE (Headache). On 15-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Rash along her stomach). On an unknown date, the patient experienced HOT FLUSH (full body hot flush) and FLUSHING (flushing). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, DYSAESTHESIA (Immediate sensation all over body), PARAESTHESIA (Tingling), FEELING ABNORMAL (felt weird), ASTHENIA (Residual weakness), RASH ERYTHEMATOUS (Rash along her stomach), HEART RATE INCREASED (Rapid heart beat), INSOMNIA (Difficult to go to sleep), RASH (little rash on her stomach), HEADACHE (Headache), HOT FLUSH (full body hot flush) and FLUSHING (flushing) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Tylenol was provided as treatment medication   This case was linked to MOD-2021-211651 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Non significant follow up received on 07-jun-2021, Patient demographics updated, concomitant medications updated. 2nd dose details updated.
pain on the arm; swelling on both clavicles; pain at the bone and shivers; on the left side a little ball right on top of the left clavicle bone; A spontaneous report was received from a consumer concerning a 46-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events swelling on both clavicles, on the left side a little ball right on top of the left clavicle bone/Furuncle, the swelling doesn't hurt/swelling, it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers/Bone pain, pain on the arm/arm pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 027L20A) intramuscularly for prophylaxis of COVID-19 infection. On 5 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: Not available) intramuscularly for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced the event(s) swelling on both clavicles. On the left side a little ball right on top of the left clavicle bone, the swelling doesn't hurt, t it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers. On an unknown date, the patient experienced the event(s) pain on the arm.  Treatment details included None.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), swelling on both clavicles, on the left side a little ball right on top of the left clavicle bone, the swelling doesn't hurt, t it moves each time that tries to touch it, it's like if it is loose, pain at the bone and shivers, pain on the arm was unknown.
Lost of smell,coper sour, joint pain, leg swelling.  frequent fever symptoms,  fatigue
booster; sciatic nerve went crazy and hurt for weeks. It appears to be affecting my nervous; sciatic nerve went crazy and hurt for weeks. It appears to be affecting my nervous; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11Nov2021 13:00 (Lot number: Fh8020) at the age of 44 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Hashimoto's thyroiditis" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Singulair, reaction(s): "Known allergies: Singulair". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Ew0161, Location of injection: Arm Right, Vaccine Administration Time: 01:30 PM), administration date: 14Apr2021, when the patient was 44 years old, for COVID-19 Immunization, reaction(s): "Skin paresthesia", "Nerve pain"; Bnt162b2 (Dose Number: 1, Batch/Lot No: Ep6955, Location of injection: Arm Right, Vaccine Administration Time: 01:30 PM), administration date: 24Mar2021, when the patient was 44 years old, for COVID-19 Immunization, reaction(s): "Nerve pain", "Skin paresthesia".  The following information was reported: IMMUNISATION (non-serious) with onset 11Nov2021 13:00, outcome "unknown", described as "booster"; SCIATIC NERVE INJURY (medically significant), SCIATIC NERVE NEUROPATHY (medically significant) all with onset 2021, outcome "unknown" and all described as "sciatic nerve went crazy and hurt for weeks. It appears to be affecting my nervous". The event "sciatic nerve went crazy and hurt for weeks. it appears to be affecting my nervous" and "sciatic nerve went crazy and hurt for weeks. it appears to be affecting my nervous" was evaluated at the physician office visit and emergency room visit. Therapeutic measures were taken as a result of sciatic nerve injury, sciatic nerve neuropathy. The patient did not have COVID prior vaccination and post vaccination.